학술논문
Nadunolimab (CAN04), a first-in-class monoclonal antibody against IL1RAP, in combination with chemotherapy in subjects with pancreatic cancer (PDAC) and non-small cell lung cancer (NSCLC)
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15698041